Advertisement

Acromegaly pp 179-191 | Cite as

Associated Hypersecretion of Anterior Pituitary Hormones other than Growth Hormone in Acromegaly

  • G. Faglia
  • M. Arosio
  • M. Bassetti
  • P. Beck-Peccoz
  • L. Guglielmino
  • A. Spada
  • G. Medri
  • G. Piscitelli
  • G. Giannattasio
  • B. Ambrosi

Abstract

Although patients showing typical features of acromegaly had been described (Fig. 1) prior to Pierre Marie’s report in 1886 (1–3), observations concerning clinical signs and symptoms assumably caused by hypersecretion of growth hormone (GH) and other pituitary hormones were reported only several years later.

Keywords

Growth Hormone Pituitary Adenoma Secretory Granule Acromegalic Patient Growth Hormone Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Verga A. Caso singolare di prosopectasia. Reale Istituto Lombardo di Scienze e Lettere, Classe Scienze Matematiche e Naturali 1864; R.cl.1,1:111.Google Scholar
  2. 2.
    Davidoff LM. Studies in acromegaly. II. Historical note. Endocrinology 1926; 10:453.CrossRefGoogle Scholar
  3. 3.
    Marie P. Sur deux cas d’acromegalie. Hypertrophic singuliere non congenitale des extremites superieures, inferieures et cephaliques. Rev Med 1886; 6:297.Google Scholar
  4. 4.
    Fraenkel A, Stadelmann E, Benda C. Klinische und anatomische Beitraege zur Lehre von der Akromegalie. Dtsch Med Wochenschr 1901; 27:513, 536, 564.CrossRefGoogle Scholar
  5. 5.
    Roth 0. Auftreten von Milchsekretion bei enem an Akromegalie leidenden patienten. Berl Klin Wchnschr 1918; 53:305.Google Scholar
  6. 6.
    Frantz AG, Kleinberg DL. Prolactin: evidence that it is separate from growth hormone in human blood. Science 1970; 170:745.PubMedCrossRefGoogle Scholar
  7. 7.
    Hwang P, Guyda H, Friesen H. A radioimmunoassay for human prolactin. Proc Natl Acad Sci USA 1971; 68:1902.PubMedCrossRefGoogle Scholar
  8. 8.
    Turkington RW. Secretion of prolactin by patients with pituitary and hypothalamic tumors. J Clin Endocrinol Metab 1972; 34:159.PubMedCrossRefGoogle Scholar
  9. 9.
    Jacobs LS, Daughaday WH. Pathophysiology and control of prolactin secretion in patients with pituitary and hypothalamic disease. In: Pasteels JL, Robyns C, eds. Human prolactin. Amsterdam: Excerpta Medica, 1973.Google Scholar
  10. 10.
    Franks S, Jacobs HS, Nabarro JDN. Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery. Clin Endocrinol (Oxf) 1976; 5:63.Google Scholar
  11. 11.
    Wass JAH, Thorner MO, Morris DV, et al. Long-term treatment of acromegaly with bromocriptine. Br Med J 1977; i:875.CrossRefGoogle Scholar
  12. 12.
    Tucker HS, Grubb SR, Wigand JP, Watlington CO, Blackard WG, Becker DP. The treatment of acromegaly by transsphenoidal surgery. Arch Intern Med 1980; 140:795.PubMedCrossRefGoogle Scholar
  13. 13.
    Arafah BM, Brodkey JS, Kaufman B, Velasco B, Manni M, Pearson OH. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism. J Clin Endocrinol Metab 1980; 50:578.PubMedCrossRefGoogle Scholar
  14. 14.
    De Pablo F, Eastman RC, Roth J, Gorden P. Plasma prolactin in acromegaly before and after treatment. J Clin Endocrinol Metab 1981; 53:344.PubMedCrossRefGoogle Scholar
  15. 15.
    Lamberts SWJ, Liuzzi A, Chiodini PG, Verde S, Klijn JGM, Birkenhager JC. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly. Eur J Clin Invest 1982; 12:151.PubMedCrossRefGoogle Scholar
  16. 16.
    Hulting A-L, Werner S, Wersaell J, Tribukait B, Anniko M. Normal growth hormone secretion is rare after microsurgical normalization of growth hormone levels in acromegaly. Acta Med Scand 1982; 212:401.PubMedCrossRefGoogle Scholar
  17. 17.
    Quabbe HJ. Treatment of acromegaly by trans-sphenoidal operation 90-Yttrium implantation and bromocriptine: results in 230 patients. Clin Endocrinol (Oxf) 1982; 16:107.CrossRefGoogle Scholar
  18. 18.
    Nieuwenhuijzen Kruseman AC, Bots GThAM, Roelfsema F, Froelich M, Van Dulken H. Immunocytochemical growth hormone and prolactin in pituitary adenomas causing acromegaly and their relationship to basal serum hormone. Clin Endocrinol (Oxf) 1983; 19:1.CrossRefGoogle Scholar
  19. 19.
    Kanie N, Kageyama N, Kuwayama A, Nakane T, Watanabe M, Kwaoi A. Pituitary adenomas in acromegalic patients: an immunohistochemical study with special reference to prolactin-secreting adenoma. J Clin Endocrinol Metab 1982; 57:1093.CrossRefGoogle Scholar
  20. 20.
    Teasdale G. Surgical management of pituitary adenoma. Clin Endocrinol Metab 1983; 121:789.CrossRefGoogle Scholar
  21. 21.
    Lamberg B-A, Ripatti S, Gordin A, Juustila H, Sivula A, Bjorkesten G. Chromophobe pituitary adenoma with acromegaly and TSH-induced hyperthyroidism associated with parathyroid adenoma. Acta Endocrinol (Copenh) 1969; 60:157.Google Scholar
  22. 22.
    MacFarlane IA, Beardwell CG, Shalet SM, Darbyshire PJ, Hayward E, Sutton ML. Glycoprotein hormone alpha-subunit secretion by pituitary adenomas: influence of external irradiation. Clin Endocrinol (Oxf) 1980; 13:215.CrossRefGoogle Scholar
  23. 23.
    MacFarlane IA, Beardwell CG, Shalet SM, Ainsle G, Rankin E. Glycoprotein hormone alpha-subunit secretion by pituitary adenomas: influence of TRH, LHRH and bromocriptine. Acta Endocrinol (Copenh) 1982; 99:847.Google Scholar
  24. 24.
    Heitz PU. Multihormonal pituitary adenomas. Horn Res 1979; 10:1.CrossRefGoogle Scholar
  25. 25.
    Melmed S, Braunstein GD, Horvath E, Ezrin C, Kovacs K. Pathophysiology of acromegaly. Endocr Rev 1983; 4:271.PubMedCrossRefGoogle Scholar
  26. 26.
    Schatz H, Daun M, Leicht R, Stracke H, Saeger W, Zierski J. Immunohistochemical examination of pituitary adenomas. Comparison to clinical and endocrinological findings. Horm Res 1985; 21:246.PubMedCrossRefGoogle Scholar
  27. 27.
    Tournaire J, Trouillas J, Chalender D, Bonneton-Emptoz A, Goutelle A, Girod C. Somatotropic adenoma manifested by galactorrhea without acromegaly. J Clin Endocrinol Metab 1985; 61:451.CrossRefGoogle Scholar
  28. 28.
    Badawy SZA, Anderson GH, Shende MC, Marshall L. Development of acromegaly in a patient with prolactinemia: a case study. Fertil Steril 1984; 42:926.PubMedGoogle Scholar
  29. 29.
    Tolis G, Bertrand G, Carpenter S, McKenzie JM. Acromegaly and galactorrhea-amenorrhea with two pituitary adenomas secreting growth hormone and prolactin. Ann Intern Med 1978; 89:343.Google Scholar
  30. 30.
    Lamberts SWJ, Klijn JGM, Kwa GH, Birkenhaeger JC. The dynamics of growth hormone and prolactin secretion in acromegalic patients with mixed tumors. Acta Endocrinol (Copenh) 1979; 90:198.Google Scholar
  31. 31.
    Lamberts SWJ, Klijn JGM, van Vroonhoven CCJ, Stefanko SZ. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. J Clin Endocrinol Metab 1985; 60:1148.PubMedCrossRefGoogle Scholar
  32. 32.
    Zimmerman EA, Defendini R, Frantz AG. Prolactin and growth hormone in patients with pituitary adenomas. A correlative study of hormone in tumor and plasma by immunoperoxidase technique and radioimmuno-assay. J Clin Endocrinol Metab 1974; 38:577.PubMedCrossRefGoogle Scholar
  33. 33.
    Ishibashi M, Yamaji T. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. J Clin Endocrinol Metab 1985; 60:985.PubMedCrossRefGoogle Scholar
  34. 34.
    Camanni F, Massara JF, Santia M, Molinatti GM, Mantegazza P, Muller EE. Impaired prolactin responsiveness to dopamine antagonists in acromegaly. Metabolism 1982; 31:1090.PubMedCrossRefGoogle Scholar
  35. 35.
    Prescott RWG, Weightman DR, Kendall-Taylor P, Johnston DG. Different and PRL responses to dopamine receptor blockade in acromegaly. Clin Endocrinol (Oxf) 1984; 21:369.CrossRefGoogle Scholar
  36. 36.
    Liuzzi A, Chiodini PG, Botalla L, Silvestrini F, Muller EE. Growth hormone-releasing activity of TRH and GH lowering effect of dopaminergic drugs in acromegaly: homogeneity of the two responses. J Clin Endocrinol Metab 1974; 39:871.PubMedCrossRefGoogle Scholar
  37. 37.
    Horvath E, Kovacs K, Killinger DW, Smyth HS, Weiss MH, Ezrin C. Mammosomatotroph cell adenoma of the human pituitary: a morphologic entity. Virchows Arch [A] 1983; 398:277.CrossRefGoogle Scholar
  38. 38.
    Bassetti M, Spada A, Arosio M, Vallar L, Brina M, Giannattasio G. Morphological studies on mixed growth hormone (GH)- and prolactin-(PRL) human pituitary adenomas. Coexistence of GH and PRL in the same secretory nodule. J Clin Endocrinol Metab 1986; 62:1093.PubMedCrossRefGoogle Scholar
  39. 39.
    Faglia G, Beck-Peccoz P, Piscitelli G, Medri G. Pituitary inappropriate secretion of thyrotropin. Horm Res (in press).Google Scholar
  40. 40.
    Beck-Peccoz P, Piscitelli G, Medri G, Ballabio M, Faglia G. Thyroid test strategy. Lancet 1985; i:1456.Google Scholar
  41. 41.
    Beck-Peccoz P, Piscitelli G, Amr S, et al. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of THS with increased bioactivity. J Clin Endocrinol Metab 1986; 62:704.PubMedCrossRefGoogle Scholar
  42. 42.
    Lamberts SWJ, Oosterom R, Verleun T, Krenning EP, Assies JH. Regulation of hormone release by cultured cells from a thyrotropin-growth hormone secreting tumor. Direct inhibiting effects of 3,5,3’-triiodothyronine and dexamethasone on thyrotropin secretion. J Endocrinol Invest 1984; 7:313.PubMedGoogle Scholar
  43. 43.
    Kourides IA, Weintraub BD, Ridgway EC, Maloof F. Secretion of alpha-subunit of glycoprotein hormones by pituitary adenomas. J Clin Endocrinol Metab 1976; 43:97.PubMedCrossRefGoogle Scholar
  44. 44.
    Beck-Peccoz P, Bassetti M, Spada A, et al. Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell. J Clin Endocrinol Metab 1985; 61:541.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • G. Faglia
    • 1
  • M. Arosio
    • 1
  • M. Bassetti
    • 2
  • P. Beck-Peccoz
    • 1
  • L. Guglielmino
    • 1
  • A. Spada
    • 1
  • G. Medri
    • 1
  • G. Piscitelli
    • 1
  • G. Giannattasio
    • 2
  • B. Ambrosi
    • 1
  1. 1.Department of Endocrinology, School of MedicineUniversity of MilanMilanoItaly
  2. 2.CNR Center of Cytopharmacology, Department of PharmacologyUniversity of MilanMilanoItaly

Personalised recommendations